Drug screening is a technical analysis of biological specimens such as blood, urine, sweat, breath, oral fluid/saliva, and hair. Drug screening involves testing of the samples such as urine, breath, oral fluid, breath, hair, and others for presence of any substances over the limit. This is done to identify that a whether a person is under the influence of alcohol or drugs, which could cause potential road accidents or other workplace issues. Pharmaceutical companies around the globe such as Abbot Laboratories provide drug screening tests that are used at workplace, government organizations, rehabilitation centers, and other places. These tests are painless and non-invasive. Furthermore, pharmaceutical companies such as Alere, Inc. offer point-of-care diagnostic tests for drugs screenings. These tests are crucial as drug addict individuals involved certain professions as commercial air pilots or air traffic controllers can risk safety of others, which can be prevented by urine testing. Urine test is a painless test and examines the presence of prescription drugs such as marijuana, cocaine, benzodiazepines, methamphetamines, methadone, benzodiazepines, and narcotics. Moreover, drug rehabilitation centers need to test of residents of a regular basis, so as to ensure the soberness among the patients. ON the contrary, oral fluid test and breath test are conducted to analyze the presence of alcohol in the body or to identify its level. Advent of novel drug test equipment and tests are expected to drive growth of the global drug screening market.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1696
Global Drug Screening Market Drivers
Growing competition among key players around the world is expected to drive growth of the global drug screening market during the forecast period. Major companies in the market are focused on developing innovative products, in order to gain competitive edge in the market. For Instance, in 2016, Alere, Inc., in partnership with GenPrime, Inc., introduced point-of-care testing device ‘xReader’ for workplace drug testing. In 2017, Alere, Inc. launched ‘Alere iCup Rx’ drug screen test for detection of commonly misused and abused prescription drugs. Furthermore, technological advancements in the industry are expected to propel the market growth in the near future. For instance, in 2017, Intelligent Fingerprinting Limited introduced a non-invasive portable fingerprint drug test. Growing incidence of traffic accidents due to drunk-driving or under the influence of drug is expected to boost the market growing during the forecast period. For instance, in November 2017, five Michigan Counties introduced pilot roadside drug testing, which utilized Alere DDS2 oral fluid test instrument to identify opioids, marijuana, and other drugs. Moreover, in 2017, Captiva Lab introduced an oral fluid drug testing, integrated with mass spectrometry to incorporate an oral fluid test panel. Growing demand from several places where drug screening could be required is such as hospitals, government organizations, and other workplaces is expected to boost the market growth in the near future. For instance, in May 2018, Phenomenex, Inc. introduced Strata-X-Drug B Plus, which is a solid phase extraction (SPE) sample preparation product for urine drug testing.
However, prohibition of drugs and alcohol at government organizations and other workplaces coupled growing awareness among people about drink and drive are expected to restrain the global drug screening market growth over the forecast period.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1696
Global Drug Screening Market Insights
Among regions, North America and Europe are expected to hold dominant position in the global drug screening market during the forecast period. This is owing to presence of leading manufacturers such as Alere, Inc. Moreover, key players are involved in business strategies such as mergers and acquisitions, which is expected to bolster growth of the market. For instance, in 2017, Abbott Laboratories acquired Alere, Inc., a U.S.-based manufacturer of rapid point-of-care diagnostic test. Furthermore, Asia Pacific is expected to witness significant growth over the forecast period, owing to increasing presence of leading manufacturers in the region. For instance, in 2016, Alere Medical Pvt. Ltd. launched integrated facility in India for manufacturing rapid point-of-care diagnostic devices. The company intends to make India an export hub for rapid diagnostic devices in Asia Pacific region.
Global Drug Screening Market Competitive Landscape
Key players operating in the global drug screening market include Thermo Fisher Scientific, Quest Diagnostics, Omega Laboratories, Abbott Laboratories, Danaher Corporation, Express Diagnostics International Inc., Siemens Healthineers, Alfa Scientific Designs, F. Hoffmann La Roche, SureHire, and OraSure.
Global Drug Screening Market Taxonomy-
The global drug screening market is segmented on the basis of product type, application, end user, and region.
By Product Type-
- Immunoassay analyzers
- Chromatography Instruments
- Drug testing Cups
- Dip Cards
- Oral Fluid Testing Products
By Application –
- Urine Testing
- Breath Testing
- Oral Fluid Testing
- Hair Testing
By End-User –
- Rehabilitation Centers
- Drug Testing Laboratories
By Region –
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027